The Sharks signed forward Oskar Lindblom to a two-year contract, general manager Mike Grier announced on Wednesday.
The terms of the deal were not disclosed.
"Oskar is a proven forward who can provide offensive upside in the middle of our lineup," said Grier. "He has overcome significant obstacles in his young career and his strength and desire to play hockey is immeasurable. We are happy to have him join our organization."
Lindblom, 25, was drafted in 2014 by the Philadelphia Flyers where he started on the affiliate team before making his way up to the NHL in 2018.
With the Flyers, the Swede played in 263 regular season games and six playoff games, scoring a total of 97 points (50 goals, 47 assists) from 2018-2022.
On December 10, 2019, Lindblom was diagnosed with Ewing’s sarcoma, a kind of bone cancer.
Lindblom completed his chemotherapy treatments several months later, and was later named the recipient of the 2019-20 Masterton Trophy at the end of the NHL season.
The annual NHL accolade is awarded to the player who best exemplifies qualities of perseverance, sportsmanship and dedication to the game.
On April 18, 2021, the Flyers honored Lindblom at their annual Hockey Fights Cancer game, which was the first time the star had returned to play on the ice post-cancer diagnosis and treatment.